The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Belousov A.S.

Moscow City Polyclinic No. 5, Clinical Diagnostic Center No. 4

Sturov N.V.

Patrice Lumumba Peoples’ Friendship University of Russia

Internal Affairs

Authors:

Belousov A.S., Sturov N.V.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(10): 38‑44

Read: 148 times

To cite this article:

Belousov AS, Sturov NV. Internal Affairs. Non Nocere. New Therapeutic Journal. 2025;(10):38‑44. (In Russ.)

References:

  1. Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018 Apr 28;391(10131):1706-1717. https://doi.org/10.1016/S0140-6736(18)30841-9
  2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2024 Report) (Date of Access: 15.08.2025). https://goldcopd.org/2024-gold-report/
  3. Li N, Dai Z, Wang Z, et al. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. Respir Res. 2021 Oct 25;22(1):274.  https://doi.org/10.1186/s12931-021-01872-z
  4. Durack J, Lynch SV. The gut microbiome: Relationships with disease and opportunities for therapy. J Exp Med. 2019 Jan 7;216(1):20-40.  https://doi.org/10.1084/jem.20180448
  5. Nie P, Li Z, Wang Y, et al. Gut microbiome interventions in human health and diseases. Med Res Rev. 2019 Nov;39(6):2286-2313. https://doi.org/10.1002/med.21584
  6. Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017 Jan;15(1):55-63.  https://doi.org/10.1038/nrmicro.2016.142
  7. Chakradhar S. A curious connection: Teasing apart the link between gut microbes and lung disease. Nat Med. 2017 Apr 7;23(4):402-404.  https://doi.org/10.1038/nm0417-402
  8. Wang L, Cai Y, Garssen J, Henricks PAJ, Folkerts G, Braber S. The Bidirectional Gut-Lung Axis in Chronic Obstructive Pulmonary Disease. Am J RespirCrit Care Med. 2023 May 1;207(9):1145-1160. https://doi.org/10.1164/rccm.202206-1066TR
  9. Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev GastroenterolHepatol. 2017 Aug;14(8):491-502.  https://doi.org/10.1038/nrgastro.2017.75
  10. Brassard P, Vutcovici M, Ernst P, et al. Increased incidence of inflammatory bowel disease in Québec residents with airway diseases. EurRespir J. 2015 Apr;45(4):962-928.  https://doi.org/10.1183/09031936.00079414
  11. Raftery AL, Tsantikos E, Harris NL, Hibbs ML. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease. Front Immunol. 2020 Sep 11;11:2144. https://doi.org/10.3389/fimmu.2020.02144
  12. Berkowitz L, Schultz BM, Salazar GA, et al. Impact of Cigarette Smoking on the Gastrointestinal Tract Inflammation: Opposing Effects in Crohn’s Disease and Ulcerative Colitis. Front Immunol. 2018 Jan 30;9:74.  https://doi.org/10.3389/fimmu.2018.00074
  13. Garrow D, Delegge MH. Risk factors for gastrointestinal ulcer disease in the US population. Dig Dis Sci. 2010 Jan;55(1):66-72.  https://doi.org/10.1007/s10620-008-0708-x
  14. Ahn SV, Lee E, Park B, et al. Cancer development in patients with COPD: a retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea. BMC Pulm Med. 2020 Jun 15;20(1):170.  https://doi.org/10.1186/s12890-020-01194-8
  15. Kim J, Lee JH, Kim Y, et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med. 2013 Aug 9;13:51.  https://doi.org/10.1186/1471-2466-13-51
  16. Gomes-Filho IS, Cruz SSD, Trindade SC, et al. Periodontitis and respiratory diseases: A systematic review with meta-analysis. Oral Dis. 2020 Mar;26(2):439-446.  https://doi.org/10.1111/odi.13228
  17. Lochhead P, Khalili H, Ananthakrishnan AN, Richter JM, Chan AT. Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2016 Jun;14(6):818-824.e6.  https://doi.org/10.1016/j.cgh.2016.01.016
  18. Matera MG, Calzetta L, Cazzola M. TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water. Pulm Pharmacol Ther. 2010 Apr;23(2):121-128.  https://doi.org/10.1016/j.pupt.2009.10.007
  19. Pugliese D, Felice C, Papa A, et al. Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future. Expert Rev ClinImmunol. 2017 Mar;13(3):223-233.  https://doi.org/10.1080/1744666X.2017.1243468
  20. Barnes PJ. Unexpected failure of anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease. Am J RespirCrit Care Med. 2007 May 1;175(9):866-867.  https://doi.org/10.1164/rccm.200702-253ED
  21. Nagaraju GP, Bramhachari PV, Raghu G, El-Rayes BF. Hypoxia inducible factor-1α: Its role in colorectal carcinogenesis and metastasis. Cancer Lett. 2015 Sep 28;366(1):11-18.  https://doi.org/10.1016/j.canlet.2015.06.005
  22. Ramsheh MY, Haldar K, Esteve-Codina A, et al. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis. Lancet Microbe. 2021 Jul;2(7): e300-e310. https://doi.org/10.1016/S2666-5247(21)00035-5
  23. Madapoosi SS, Cruickshank-Quinn C, Opron K, et al. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2022 Aug 15;206(4):427-439.  https://doi.org/10.1164/rccm.202110-2241OC
  24. Parada Venegas D, De la Fuente MK, Landskron G, et al. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front Immunol. 2019 Mar 11;10:277.  https://doi.org/10.3389/fimmu.2019.00277
  25. Young RP, Hopkins RJ, Marsland B. The Gut-Liver-Lung Axis. Modulation of the Innate Immune Response and Its Possible Role in Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol. 2016 Feb;54(2):161-169.  https://doi.org/10.1165/rcmb.2015-0250PS
  26. Freedman SB, Schnadower D, Tarr PI. The Probiotic Conundrum: Regulatory Confusion, Conflicting Studies, and Safety Concerns. JAMA. 2020 Mar 3;323(9):823-824.  https://doi.org/10.1001/jama.2019.22268
  27. Mindt BC, DiGiandomenico A. Microbiome Modulation as a Novel Strategy to Treat and Prevent Respiratory Infections. Antibiotics. 2022;11(4):474.  https://doi.org/10.3390/antibiotics11040474

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.